The effects of different doses of medroxyprogesterone acetate on serum lipids, lipoprotein levels and atherogenic index in the menopausal period

Gynecological Endocrinology

Volumn 12, Issue 4, 1998, Pages 267-272

  Aygen, E M ^a   Basbug M ^a   Tayyar, M ^a   Kaya, E ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Atherogenic index; Lipids and lipoprotein profiles; Progestins

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; TRIACYLGLYCEROL;

ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYSTERECTOMY; LIPID BLOOD LEVEL; MENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031659612     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599809015599     Document Type: Article

References (20)

1. Bolaji II, Grimes SH, Mortimer G, et al. Low-dose progesterone therapy in oestrogenised postmenopausal women: effect on plasma lipids, lipoproteins and liver function parameters. Eur J Obstet Gynecol Reprod Biol 1993;48:61-8
2. Paganini-Hill A, Dworsky R, Krauss RM. Hormone replacement therapy, hormone levels, and lipoprotein cholesterol concentrations in elderly women. Am J Obstet Gynecol 1996;174:897-902
3. Ottosen B, Pedersen AT. Physiological effects of ovarian hormones: clinical aspects and compliance. Eur Heart J 1996;17(Suppl D):20-6
4. Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility. Baltimore: Williams and Wilkins, 1994:583-651
5. Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility. Baltimore: Williams and Wilkins, 1994:651-66
6. Atasü T, Şahmay S. Jinekoloji. Istanbul: Üniversal bilimsel yayinlan, 1996:635-47
7. Sonnendecker EW, Polakow ES, Benade AJS, et al. Serum lipoprotein effect of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women. Am J Obstet Gynecol 1989;160:1128-34
8. Stevenson JC. Are changes in lipoproteins during HRT important. Br J Obstet Gynaecol 1996;103 (Suppl 13):39-44
9. Castelli WP. Cardiovascular disease in women. Am J Obstet Gynecol 1988;158:1553-60
10. Schenck-Gustafsson K. Risk factors for cardiovascular disease in women: assessment and management. Eur Heart J 1996;17(Suppl D):2-8
11. Yancey MK, Hannan CJ, Plymate SR, et al. Serum lipids and lipoproteins in continuous or cyclic medroxyprogesterone acetate treatment in postmenopausal women treated with conjugated estrogens. Fertil Steril 1990;54:778-82
12. Hirvonen E, Malkonen M, Manninen V. Effect of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med 1981;304:560-3
13. Anonymous. Effects of estrogen or estrogen/progestin regimens on heart disease risk factor in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial. J Am Med Assoc 1995;273:199-208
14. Walsh DW, Schiff I, Rosner B, et al. Effect of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-1204
15. Tadmor OP, Kleinman Y, Reisin A, et al. The effects of two fixed hormonal replacement therapy protocols on blood lipid profile. Eur J Obstet Gynecol Reprod Biol 1992;46:109-16
16. Crock D, Cust MP, Gangar KF, et al. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. Am J Obstet Gynecol 1992;166:950-5
17. Lobo RA, Pickar JH, Wild RA, et al. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. Obstet Gynecol 1994;84:987-95
18. Makkonen M, Saarikoski S, Penttila I. Effects of oestradiol valerate plus two different progestogens on serum lipids during post-menopausal replacement therapy. Maturitas 1991;14:43-8
19. Saure A, Hirvonen E, Tiokkanen MJ, et al. A novel oestradiol-desogestrel preparation for hormone replacement therapy: effects on hormones, lipids, bone climacteric symptoms and endometrium. Maturitas 1993;16:1-12
20. Hirvonen E, Lipasti A, Malkonen M, et al. Clinical and lipid metabolic effects of unopposed oestrogen and two progesterone regimen in post-menopausal women. Maturitas 1987;9:69-74